143 related articles for article (PubMed ID: 6140635)
1. Atypical neuroleptics: clozapine and the benzamides in the prevention and treatment of tardive dyskinesia.
Pi EH; Simpson GM
Mod Probl Pharmacopsychiatry; 1983; 21():80-6. PubMed ID: 6140635
[No Abstract] [Full Text] [Related]
2. Treatment of tardive dyskinesia.
Deleu D
Am J Psychiatry; 1988 Sep; 145(9):1182-3. PubMed ID: 2901238
[No Abstract] [Full Text] [Related]
3. Treatment of tardive dyskinesia.
Roos RA; Buruma OJ; de Wolff FA
Clin Neuropharmacol; 1988 Aug; 11(4):386. PubMed ID: 3061638
[No Abstract] [Full Text] [Related]
4. Treatment of permanent tardive dyskinesia with tiapride, a selective D2-receptor blocking agent.
Leblhuber F
Clin Neuropharmacol; 1987 Oct; 10(5):458-61. PubMed ID: 2902921
[No Abstract] [Full Text] [Related]
5. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ
J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310
[TBL] [Abstract][Full Text] [Related]
6. Effect of clozapine in severe tardive dyskinesia: a case report.
Meltzer HY; Luchins DJ
J Clin Psychopharmacol; 1984 Oct; 4(5):286-7. PubMed ID: 6149239
[TBL] [Abstract][Full Text] [Related]
7. Clozapine for tardive dyskinesia in adolescents.
Levkovitch Y; Kronenberg J; Kayser N; Zvyagelski M; Gaoni B; Gadoth N
Brain Dev; 1995; 17(3):213-5. PubMed ID: 7573764
[TBL] [Abstract][Full Text] [Related]
8. Tiapride in the treatment of tardive dyskinesia.
Buruma OJ; Roos RA; Bruyn GW; Kemp B; van der Velde EA
Acta Neurol Scand; 1982 Jan; 65(1):38-44. PubMed ID: 6121443
[TBL] [Abstract][Full Text] [Related]
9. Tiapride: effects on tardive dyskinesia and on prolactin plasma concentrations.
Greil W; Auberger S; Haag H; Rüther E
Neuropsychobiology; 1985; 14(1):17-22. PubMed ID: 3906426
[TBL] [Abstract][Full Text] [Related]
10. Successful therapy of tardive dyskinesia in a 71-year-old woman with a combination of tetrabenazine, olanzapine and tiapride.
Koch HJ; Szecsey A; Vogel M; Fischer-Barnicol D
Int J Clin Pract; 2003 Mar; 57(2):147-9. PubMed ID: 12661802
[TBL] [Abstract][Full Text] [Related]
11. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
Glazer WM
J Clin Psychiatry; 2000; 61 Suppl 4():21-6. PubMed ID: 10739327
[TBL] [Abstract][Full Text] [Related]
12. Clozapine and tardive dyskinesia.
Singer JM
Arch Gen Psychiatry; 1983 Mar; 40(3):347-8. PubMed ID: 6338857
[No Abstract] [Full Text] [Related]
13. Clozapine in tardive dyskinesia.
Simpson GM; Lee JH; Shrivastava RK
Psychopharmacology (Berl); 1978 Jan; 56(1):75-80. PubMed ID: 415329
[TBL] [Abstract][Full Text] [Related]
14. Clozapine in tardive dyskinesia: observations from human and animal model studies.
Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM
J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
[TBL] [Abstract][Full Text] [Related]
15. Effects of tiapride in tardive dyskinesia.
Pollak P; Gaio JM; Hommel M; Pellat J; Perret J
Psychopharmacology (Berl); 1985; 85(2):236-9. PubMed ID: 3925489
[TBL] [Abstract][Full Text] [Related]
16. Treatment of clozapine-associated tardive dyskinesia.
Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
[No Abstract] [Full Text] [Related]
17. [Influence of clozapine on neuroleptigenic extrapyramidal motor disturbances (author's transl)].
Zander KJ; Rüther E
Arzneimittelforschung; 1978; 28(9):1495-6. PubMed ID: 38808
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the therapeutic range of tiapride in patients with tardive dyskinesia.
Roos RA; Van der Velde EA; Buruma OJ; de Wolff FA
J Neurol Neurosurg Psychiatry; 1986 Sep; 49(9):1055-8. PubMed ID: 3760895
[TBL] [Abstract][Full Text] [Related]
19. Clozapine in tardive Tourette syndrome.
Jaffe E; Trémeau F; Sharif Z; Reider R
Biol Psychiatry; 1995 Aug; 38(3):196-7. PubMed ID: 7578666
[No Abstract] [Full Text] [Related]
20. Tardive dystonia induced by switch of atypical antipsychotics.
Chen CC; Chen YY; Hung GC
Pharmacopsychiatry; 2010 Jul; 43(5):200-1. PubMed ID: 20486043
[No Abstract] [Full Text] [Related]
[Next] [New Search]
